Bromodomain Inhibitors
Learn MoreFAAH inhibitors are a class of compounds that have emerged as promising therapeutic agents in the field of neurology and pain management FAAH or fatty acid amide hydrolase is an enzyme that breaks down endocannabinoids which are natural compounds that play a crucial role in regulating pain mood and inflammation By inhibiting FAAH these compounds allow endocannabinoids to accumulate and exert their therapeutic effects for a longer duration This makes FAAH inhibitors a potential solution for conditions such as chronic pain anxiety and neuroinflammation Our company offers a range of highly effective FAAH inhibitors that have been extensively researched and tested for their safety and efficacy
Catalog Number | Chemical Name | CAS # | Price |
---|---|---|---|
BC-0208 | Biochanin A | 491-80-5 | Online Inquiry |
EI-0965 | FAAH Inhibitor, PF-622 | 898235-65-9 | Online Inquiry |
EI-1252 | JNJ-1661010 | 681136-29-8 | Online Inquiry |
EI-1267 | JZL195 | 1210004-12-8 | Online Inquiry |
EI-2254 | URB597 | 546141-08-6 | Online Inquiry |
FAAH inhibitors have a wide range of applications in both research and medicine In research these inhibitors are commonly used to study the role of the fatty acid amide hydrolase (FAAH) enzyme in various biological processes By inhibiting FAAH activity scientists can better understand the impact of this enzyme on pain sensation inflammation and other physiological functions These insights can pave the way for the development of new drugs and therapies targeting the FAAH enzyme
In medicine FAAH inhibitors have shown promise as potential treatments for various conditions By blocking the activity of FAAH these inhibitors can increase levels of endocannabinoids which are natural substances that regulate pain mood and appetite This can be beneficial in managing chronic pain anxiety disorders and even obesity Additionally FAAH inhibitors may also have neuroprotective effects making them a potential therapeutic option for neurodegenerative diseases such as Alzheimer's and Parkinson's
Overall the use of FAAH inhibitors in research and medicine holds great potential for advancing our understanding of biological processes and developing innovative treatments for a range of conditions
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.